A B S T R A C T Studies of several aspects of thyroid hormone economy have been conducted in 11 patients before and after removal of a molar pregnancy. Before evacuation of the mole, all patients demonstrated moderately to greatly elevated values for thyroidal 'I uptake, absolute iodine uptake, and serum protein-bound-I. Values for serum PBI and serum thyroxine (T4) concentration were consistently and often greatly increased, averaging more than twice those found in normal pregnancy and three times those in normal controls. On the other hand, the maximum binding capacity of the T4-binding globulin (TBG) was variably affected, and ranged between the values found in normal controls and those found in normal pregnancy. Values for the absolute concentration of free T4 in serum were, on the average, only moderately elevated, since the proportion of free To was moderately low, although not as low as in normal pregnancy. Sera of patients with molar pregnancy contained high levels of thyroid stimulating activity, as assessed in the McKenzie mouse bioassay system. The stimulator displayed a more prolonged duration of action than that of TSH and did not reveal a major immunological cross-reactivity with either human or bovine TSH, differing in the latter respect from the chorionic thyrotropin of normal human placenta. Abnormalities in iodine metabolism were rapidly ameliorated after removal of the molar pregnancy, and this was Despite the foregoing evidence of thyroid hyperfunction and hypersecretion of T4, patients with molar pregnancy were neither goitrous nor overtly thyrotoxic. They did display, however, high values of the urinary pigment/creatinine ratio, a possible indication of the presence of a hypermetabolic state.
INTRODUCTION
Hydatidiform mole is the most frequent tumor of trophoblastic tissue; its frequency, geographical distribution, and pathogenesis have recently been reviewed (1). Dowling, Ingbar, and Freinkel first called attention to the occurrency of striking abnormalities in several aspects of thyroid hormone economy in patients with molar pregnancy (2) . They found marked increases in serum PBI, PB"'3I, butanol-extractable 'I, thyroidal 'I uptake, and absolute iodine uptake (AIU)' in one or more of three patients studied. More recently, Kock, Kessel, Stolte, and Leusden confirmed the elevation of PBI in six patients, and found that the resin uptake of '31I-labeled triiodothyronine (T3), assessed in two patients, was in the same range as in normal pregnancy. An 31J-tracer test performed in one patient indicated a very high thyroidal 131I uptake, conversion ratio, and thyroidal "1I-secretion rate (3) .
In all of the foregoing studies, the patients with molar pregnancy were apparently not thyrotoxic. Therefore it seemed important to ascertain whether the iodinated materials being synthesized in the thyroids of seemingly euthyroid patients with molar pregnancy were in fact thyroxine (T4), whether the increase in serum PBI represented an increase in To or other iodinated materials, and to what extent, if any, the increase could be attributed to an increase in the activity of serum thyroxine-binding globulin (TBG), analogous to that which occurs in normal pregnancy (4, 5) . The present report describes the findings obtained in 11 patients in whom several aspects of thyroid hormone economy were studied before and after termination of a molar pregnancy. As a possible index of metabolic state, measurements were also made of the urinary pigment/creatinine ratio (6) (7) (8) . Studies of thyroid hormone concentration and binding in the serum of nine other patients are also presented.
METHODS
Patient material and general procedures. All patients were studied at the Hospital de Gineco Obstetricia, numero dos, Centro Medico Nacional, Mexico City. Control oh- creatinine ratio are presented elsewhere (13) . The uptake of '31I by the thyroid was determined in the radioisotope laboratory of the Hospital General, Centro Medico Nacional, through the courtesy of Dr. A. Cuaron.
Values for the 24-hr absolute thyroidal iodine uptake (AIU) were calculated as the product of the daily urinary iodine excretion and the quotient of the thyroidal 'lI uptake and the 24-hr urinary '31I excretion.
Human pituitary TSH was measured in unextracted serum by a specific radioimmunoassay, modified from that of Odell, Rayford, and Ross (14) . The serum samples were also assayed for a placental thyrotropin in a radioimmunoassay for beef TSH using a double antibody technique described previously (15) . A thyrotropic substance extracted from normal human placentas cross-reacts in this beef immunoassay (16) . Bioassay for thyroid stimulating activity in unextracted serum samples was performed by a modification of the McKenzie mouse bioassay method (16) . Each mouse was injected intravenously with 0.5 ml serum, 4-6 mice per sample. To ascertain whether the biological activity in serum could be neutralized by anti-TSH antibody, samples of serum were reacted for 18 hr at 20C with an antibody to human pituitary TSH. The amount of antibody employed was that which produced complete neutralization of a quantity of human TSH comparable in biological activity to that of the serum sample.
Statistical analyses were conducted employing Student's t test, as described by Snedecor and Cochran (17) . (Table II) . For the laboratory in which the studies were done, the mean value for the 24-hr thyroidal uptake of "31I in nonpregnant euthyroid women was 35 ±6.5% (mean +sE), range 10-50%. In 10 patients with molar pregnancy studied before delivery, the 24-hr uptake of "I averaged 63 ±4.0% (range 41-83%), a highly significant increase (P < 0.001). Values of 50% or more were observed in 8 of the 10 patients. The lowest value (41%) was seen in patient 32 who may have been exposed to excess iodide, since urinary iodine excretion was greatly increased. In the seven patients studied after evacuation of the mole, 'I uptake declined rapidly, reaching values within the normal range by the time of first postdelivery measurement (1-4 wk).
RESULTS

Indices of thyroid function
Values for the 24-hr urinary excretion of "sI and "'I were measured during the 24-hr period in which thyroidal 'I uptake was being determined so that absolute rates of thyroidal iodine uptake could be calculated. One patient (No. 32) was found to have a greatly elevated value for urinary iodine (5250 ig/24 hr). That (2, 18, 19) . The percentage and absolute concentrations of free T4 in the serum of patients with normal and molar pregnancy are also shown in Table III . In accord with earlier observations, the percentage of free T4 in serum was significantly decreased during normal pregnancy (9, 20) . The absolute concentration of free T4 in serum, however, was only slightly, and not significantly, lower than normal. In molar pregnancy, the mean percentage of free T4 (0.039 ±0.004) was reduced to about the same degree as in normal pregnancy. However, owing to the very marked increase in serum PBI, the absolute concentration of free T4 in the serum of patients with molar pregnancy (12.7 ±2.0 ng/100 ml) was significantly higher than normal (5.5 +0.5 ng/100 ml, P < 0.05). In patients with molar pregnancy, values for the per cent and absolute concentration of free T4 had returned toward or into the normal range by 4 wk after delivery.
Thyroid Hormone Economy in Molar Pregnancy
Concern was felt about the accuracy of some of these measurements, in particular the free T4 analyses, since the equipment used in Mexico was not entirely adequate and strict regulation of the bath temperature during the equilibrium dialysis was difficult to attain. Furthermore, samples of serum were frozen for varying lengths of time before shipment to the United States for determi- Urinary pigment/creatinine ratio. Values of the urinary pigment/creatinine (P/C) ratio were approximately twice normal in patients with uncomplicated pregnancy. In molar pregnancy, the ratio was, in turn, increased to values more than twice those found in normal pregnancy (Table V) . The ratio fell rapidly during the 1st wk after evacuation of the mole, and by 4 stimulator in the serum of patients with hydatidiform mole was parallel to that of the bovine standard (21) . The dose-response curve of the International Human TSH Standard is much flatter than that for bovine TSH in this bioassay (16) and would have given higher values than those reported had responses in these sera been related to the human standard curve. In specimens obtained before delivery from 6 patients in the initial group of 11, thyrotropic activities were greatly elevated and ranged between 110 and 500 AsU/ml. In sera obtained as soon as 2 days after evacuation of the mole, no thyroid stimulator could be detected in the bioassay. The thyroid stimulator present in preevacuation sera differed from TSH in that a greater response was evident at 8 hr than at 2 hr. The ratio of responses at 8 and 2 hr ranged between 0.91 and 1.44, suggesting a longer duration of activity than that of pituitary TSH, for which the 2 hr-response regularly exceeds the 8-hr response (15) . The thyroid stimulating activity in the predelivery serum of patient 27 was unaffected by prior incubation with antibody to human TSH (Table VII) .
Radioimmunoassays for human TSH revealed values within the normal range in specimens obtained both before and after delivery of the mole (Table VI) . Unlike the thyroid stimulating material that has been extracted from normal human placentas (15) , the thy- roid stimulator present in the sera of patients with molar pregnancy did not cross-react in the radioimmunoassay for bovine TSH. Studies performed in the second group of nine sera revealed the presence of high titers of a thyroid stimulator similar in the temporal characteristics of its action to that found in the earlier group. Positive responses were obtained in sera from seven of nine patients. The two patients in whose sera the stimulator could not be detected were those in whom the PBI was the least increased. Very high titers of stimulator in patients 2, 3, and 8 (2000, 1200, and 1300 MU/ml, respectively) permitted dilution of the sera for use in four point bioassays. These assays confirmed that the slope of this thyroid stimulator was parallel to that of the bovine standard.
DISCUSSION Although previous reports have demonstrated the occurrence of thyroid hyperfunction in patients with molar pregnancy, the number of patients examined was few, and the tests performed were scattered. Hence, it was not possible to conclude whether the thyroid hyperfunction and the associated increase in serum PBI which had been described truly represented hypersecretion of thyroid hormone, particularly since clinical evidence of thyrotoxicosis was lacking. The present study comprises the largest number of observations in the largest number of patients with this disorder yet reported. While the study clarifies certain questions raised by earlier reports, others remain unanswered, and new questions have been raised. The present observations in 11 patients studied before delivery of the mole have demonstrated consistent and marked thyroidal hyperfunction, as evidenced by greatly elevated values of the thyroidal '81I uptake. That such hyperfunction was not the result of iodine deficiency was indicated by the finding of essentially normal, or occasionally increased, values for the daily urine iodine excretion, and ultimately by the demonstration that daily absolute iodine accumulation in the thyroid was increased, often greatly so. Values for thyroidal "'I uptake were well into the range found in patients with thyrotoxicosis, and those for AIU were unusually high, even for patients with thyrotoxicosis (18, 19) . More- Several of the changes in certain aspects of thyroid hormone economy which occur in molar pregnancy resemble superficially those seen in normal pregnancy. These include the increase in thyroidal 'I uptake and serum PB'JI (22) (23) (24) (25) ; in patients with molar pregnancy, however, these indices tended to be more markedly increased. Of greater importance is the fact that in normal pregnancy AIU is increased little if at all (25) , and T4 secretory rate, as judged from peripheral To disposal, is normal (26) . In the present patients with molar pregnancy, AIU was consistently increased, often well into the range found in thyrotoxicosis, while evidence for hypersecretion of T4 is present, as cited immediately above. Finally, values for serum PBI and T4 concentration in molar pregnancy were usually much greater than in normal pregnancy.
The far higher values for serum PBI and T4 in molar than in normal pregnancy cannot be explained by a greater increase in T4-binding by TBG in the former state. Indeed, on the average, values for the maximum binding capacity of TBG were lower than in normal pregnancy, although somewhat higher than in the nonpregnant female. Moreover, among patients with molar pregnancy, no correlation between values of the serum PBI and the T4-binding capacity of TBG was evident. Values for the latter varied widely, some falling within the normal range and others within the range found in normal pregnancy. In these patients measurements of urinary estrogen excretion just before induction of labor, published in detail elsewhere (27) , revealed no correlation between the binding capacity of TBG at that time and the excretion of either total estrogens or estrone and estradiol, which are far more potent than estriol in inducing an increase of TBG (28) .
In view of the variability in the T4-binding capacity of TBG and the evidence that the increased serum T4 concentration was at least partly the result of enhanced secretion of the hormone, and not solely secondary to an increase in TBG, it is not surprising that no clear correlations were evident among the T4-binding capacity of TBG, the T4 concentration, and the proportion of free T4 in the serum. Over the range which obtains in a variety of primary disorders of either thyroid function or hormonal binding, the proportion of free T4 in serum is inversely correlated with the concentration of unsaturated binding sites on TBG (29) . Such correlations were difficult to seek in the present series of patients, because in the majority of instances the total serum T4 concentration exceeded the maximum concentration of T4-binding sites on TBG, often greatly. In such cases, it would be expected that the proportion of free T4 would be substantially increased, and it seems anomalous that such was not the case; values in such cases being increased only moderately, if at all. Previous studies have suggested, however, that the extent of increase in the proportion of free T4 that occurs when binding sites on TBG are saturated depends upon the availability of binding sites on TBPA (9, 30, 31 With few exceptions (15, (32) (33) (34) , previously reported cases of trophoblastic tumor which demonstrated thyroid hyperfunction or marked increases in serum PBI were peculiar in that they failed to display signs or symptoms of frank thyrotoxicosis. A similar paradox was evident in the present series of patients, who appeared clinically euthyroid and yet presented multiple lines of evidence suggesting hypersecretion of T4. The presence of apparently normal concentrations of TSH in serum before evacuation of the mole does not, as might be expected, provide conclusive evidence against the presence of thyrotoxicosis in view of difficulty in distinguishing between normal and subnormal levels of TSH, and the possibility that any TSH actually detected might represent a weak cross-reaction between high concentrations of the molar thyroid stimulator and human TSH (21, 32, 34) . Unfortunately, conventional indices of peripheral metabolic state, such as basal metabolic rate, could not be measured. Since random urine collections could be obtained, however, measurements of the urinary P/C ratio could be made. The pronounced increase in this ratio which occurred in patients with molar pregnancy would suggest that the patients were indeed hypermetabolic, since the ratio has been shown to increase in association with hypermetabolism of either thyroidal or extrathyroidal origin (6) (7) (8) . Nevertheless, so little is known of other factors which may influence this ratio that this cannot be considered conclusive evidence that the patients were hypermetabolic, let alone thyrotoxic.
The explanation for the absence of frank thyrotoxico-sis in most patients with molar pregnancy, despite evidence of pronounced hypersecretion of T4, is unknown, but may relate to the magnitude of the increase in free T4 concentration in their serum. In patients with the usual varieties of hyperthyroidism, the absolute concentration of free To in serum is usually quite elevated as a result of increases in both the total concentration of To in serum and the proportion which is free. In most series, the absolute concentration of free To in hyperthyroid patients averages about 5 times the normal value (9, 20, 29, 30) ; in the patients with molar pregnancy, a smaller increase in the concentration of free T4 was generally seen, since the proportion of free To was usually subnormal. Small to moderate increases in the serum concentration of free To in the absence of thyrotoxicosis are also seen in some patients with nonthyroidal illness (9, 20) , as well as in patients receiving replacement doses of synthetic thyroxine (35) .' Hence, it may be, as earlier studies have also suggested (36) , that patients can tolerate moderate increments in the availability of T4 to tissues without developing frank thyrotoxicosis.
Although several questions concerning the changes in thyroid hormone economy which occur in molar pregnancy, such as the reasons for the variability in TBG or the absence of frank thyrotoxicosis, remain to be answered, it seems quite clear from the present data both that the intense thyroid hyperfunction seen in patients with molar pregnancy results from the highly active thyroid stimulator present in their serum and that the stimulator itself originates in the molar tissue. Consonant with this view is the rapid amelioration of thyroid hyperfunction and the often precipitous decrease in serum PBI associated with rapid disappearance of the stimulator from the serum after removal of the mole (Fig. 1) . The nature of the unusual stimulator is uncertain. Bioassayable thyroid stimulating activity has been detected in serum or tumor from several patients with trophoblastic neoplasms (21, 32, 37, 38) . Most germane to the present observations are the reports of Hershman and Higgins (32) , who studied two patients with molar pregnancy, both of whom were thyrotoxic. Thyroid stimulating activity was found in both serum and extracts of tumor from one patient. Like the stimulator found in the present patients, it failed to demonstrate major immunologic cross-reaction with human TSH. Moreover, unlike normal chorionic thyrotropin, it failed to cross-react with bovine TSH. Gel filtration studies suggested that the thyroid stimulator in molar tissue has a higher molecular weight 'In the studies cited (35) , the concentration of free triiodothyronine (T3) was also moderately increased. No data concerning the proportion or concentration of free Ts in the serum of patients with molar pregnancy are available. 
